STOCK TITAN

SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2022 on November 8, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

SOPHiA GENETICS (Nasdaq: SOPH) will release its Q3 fiscal 2022 financial results on November 8, 2022, before U.S. markets open. The company plans to host a conference call at 8:30 a.m. EST to discuss these results and its business outlook. Investors can access the call via the SOPHiA GENETICS Investor Relations website, where a replay will be available afterward. The firm focuses on data-driven medicine, offering the SOPHiA DDM™ Platform used by various healthcare institutions globally.

Positive
  • None.
Negative
  • None.

BOSTON and GENEVA, Switzerland, Oct. 06, 2022 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced it will release its financial results for the third quarter of fiscal 2022 before U.S. markets open on Tuesday, November 8, 2022. SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:30 a.m. EST / 2:30 p.m. CET.

The call will be webcast live on the SOPHiA GENETICS Investor Relations website. Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS:
SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM, or connect on TwitterLinkedIn, Facebook, and Instagram. Where others see data, we see answers

Investor Contact:
Jennifer Pottage
Head of Investor Relations
ir@sophiagenetics.com

Media Contact:
Kelly Katapodis
Senior Manager, Media & Communications
media@sophiagenetics.com


FAQ

When will SOPHiA GENETICS release its third quarter financial results?

SOPHiA GENETICS will release its third quarter financial results on November 8, 2022.

What time is the SOPHiA GENETICS conference call for Q3 results?

The conference call for SOPHiA GENETICS Q3 results will begin at 8:30 a.m. EST.

How can I access the SOPHiA GENETICS financial results conference call?

You can access the conference call by visiting the SOPHiA GENETICS Investor Relations website.

What is the focus of SOPHiA GENETICS?

SOPHiA GENETICS focuses on establishing data-driven medicine as the standard of care in healthcare.

SOPHiA GENETICS SA Ordinary Shares

NASDAQ:SOPH

SOPH Rankings

SOPH Latest News

SOPH Stock Data

205.96M
62.57M
5.82%
53.4%
0.09%
Health Information Services
Healthcare
Link
United States of America
Rolle